I’m starting a new trial that inhibits the kras mutation. This is a pan kras inhibitor so works on all the variations of kras mutations. The oncologist said there has been some success in other cancers that involve the kras mutation like pancreatic and lung cancer. Hopefully it shrinks the cancer and eventually destroys it but I’ll be happy if it just stops it growing for a while.
Side effects are the usual gi issues and potential liver abnormalities.
New trial kras inhibitor
New trial kras inhibitor
09/20:Diagnosed
10/20: LAR tumour t3n2m1 4/24 lymph nodes.
11/20: pet scan confirmed Mets
11/20: folfoxiri - 10/6/21. 12 rounds in total
1/1/21 thoracotomy 1 met removed
2/2022 sabr to 2 lung nodule
09/22 PET scan progression
10/22 phase 1 trial bispecific antibody
9/23 added pd1 blocker
12/23 bilateral VATS all visible (7) lesions removed
3/24 radiation to acromion bone met + chest lymph nodex
8/24 new pet positive lesions in lung and neck lymph nodes. Begin Folfiri.
3/25 phase 1 kras inhibitor trial
10/20: LAR tumour t3n2m1 4/24 lymph nodes.
11/20: pet scan confirmed Mets
11/20: folfoxiri - 10/6/21. 12 rounds in total
1/1/21 thoracotomy 1 met removed
2/2022 sabr to 2 lung nodule
09/22 PET scan progression
10/22 phase 1 trial bispecific antibody
9/23 added pd1 blocker
12/23 bilateral VATS all visible (7) lesions removed
3/24 radiation to acromion bone met + chest lymph nodex
8/24 new pet positive lesions in lung and neck lymph nodes. Begin Folfiri.
3/25 phase 1 kras inhibitor trial
Re: New trial kras inhibitor
Rooting for you, Markdale!
-
I_will_fight
- Posts: 167
- Joined: Mon Jun 29, 2020 3:38 pm
Re: New trial kras inhibitor
Markdale wrote:I’m starting a new trial that inhibits the kras mutation. This is a pan kras inhibitor so works on all the variations of kras mutations. The oncologist said there has been some success in other cancers that involve the kras mutation like pancreatic and lung cancer. Hopefully it shrinks the cancer and eventually destroys it but I’ll be happy if it just stops it growing for a while.
Side effects are the usual gi issues and potential liver abnormalities.
Hi Marks, thank for the info.
May I ask you more which mutation you have? do you know which drug or molecule is being trialed ? Did they mention eithe sotorasib or adagrasib?
Hoping it works for you!
Thank you, Best Regards
Javi
46 yo male Spain
06/2020 - 6cm T3N0M0 CC splenic flex
3 and 4 mm lung ground glass
lymp 0/37
dMMR MSH6
KRAS mt G13D
V/LNI absent
PNI present
07/20 - hemicol surg, optimistic surgeon.
11/20 - 4 x CAPOX completed.
12/20 - Clear colonoscopy
02/21 - MRI liver lesion unchanged.
11/21 - Clear CT
02/22- Colonoscopy: Sessil polyp 3mm
05/22- Clear CT
06/22- Negative Signatera
12/22- Negative Signatera
01/23- Clear CT
07/23- Clear CT, normal markers.
09/23 - Negative Signatera
01/24 - Clear CT
01/25 - Clear CT
06/2020 - 6cm T3N0M0 CC splenic flex
3 and 4 mm lung ground glass
lymp 0/37
dMMR MSH6
KRAS mt G13D
V/LNI absent
PNI present
07/20 - hemicol surg, optimistic surgeon.
11/20 - 4 x CAPOX completed.
12/20 - Clear colonoscopy
02/21 - MRI liver lesion unchanged.
11/21 - Clear CT
02/22- Colonoscopy: Sessil polyp 3mm
05/22- Clear CT
06/22- Negative Signatera
12/22- Negative Signatera
01/23- Clear CT
07/23- Clear CT, normal markers.
09/23 - Negative Signatera
01/24 - Clear CT
01/25 - Clear CT
Re: New trial kras inhibitor
Mark,
What is the name of the trial drug you are taking?
Paige
What is the name of the trial drug you are taking?
Paige
02/20 Rectal Cancer dx - 4 cm mass; located 9 cm from AV
CEA 1.4; 0.9; 0.9; 1.2; 1.0; 0.8; 1.1; 1.0; 1.1; 1.7; 1.8; 1.8; 1.9
2.4; 2.3; 2.8; 2.2, 2.8, 3.2; 3.0; 1.6; 2.0; 1.2; 1.4; 1.2; 1.0; 1.2; 1.2
04/20 ST Radiation; 04/20 LAR surgery w/ileostomy; ypT3N1bM0; MSS, KRAS G12A
05/20 CAPEOX; 08/20 Ileostomy reversal
12/20 CT scan; lung nodules (watch and wait);
11/22 lung nodule biopsy positive for RC met;
1/23 VATS right lower lobe wedge resection
FOLFIRI 10 cycles
4/24 left brain craniotomy (RC met)
CEA 1.4; 0.9; 0.9; 1.2; 1.0; 0.8; 1.1; 1.0; 1.1; 1.7; 1.8; 1.8; 1.9
2.4; 2.3; 2.8; 2.2, 2.8, 3.2; 3.0; 1.6; 2.0; 1.2; 1.4; 1.2; 1.0; 1.2; 1.2
04/20 ST Radiation; 04/20 LAR surgery w/ileostomy; ypT3N1bM0; MSS, KRAS G12A
05/20 CAPEOX; 08/20 Ileostomy reversal
12/20 CT scan; lung nodules (watch and wait);
11/22 lung nodule biopsy positive for RC met;
1/23 VATS right lower lobe wedge resection
FOLFIRI 10 cycles
4/24 left brain craniotomy (RC met)
-
beach sunrise
- Posts: 1220
- Joined: Thu Mar 05, 2020 7:14 pm
Re: New trial kras inhibitor
Great you found this kRAS inhibitor and I so hope the best for you. Please keep us updated as this is probably the first for kRAS.
To combat kRAS I have only found IV vitamin C, Cordyceps and shikonin (TCM).
To combat kRAS I have only found IV vitamin C, Cordyceps and shikonin (TCM).
8/19 RC CEA 82.6 T3N0M0
5FU/rad 6 wk
IVC 75g 1 1/2 wks before surgery. Continue 2x a week
Surg 1/20 -margins T4bN1a IIIC G2 MSI- 1/20 LN+ LVI+ PNI-
pre cea 24 post 5.9
FOLFOX
7 rds 6-10 CEA 11.4 No more
CEA
7/20 11.1 8.8
8/20 7.8
9/20 8.8, 9, 8.6
10/20 8.1
11/20 8s
12/20 8s-9s
ADAPT++++ chrono
CEA
10/23/22 26.x
12/23/22 22.x
2023
1/5 17.1
1/20 15.9
3/30 14.9
6/12 13.3
Nodule RML SUV 1.3 5mm
Rolles 3 of 4 lung nodules cancer
KRAS
Chem-sens test failed Not enough ca cells to test
5FU/rad 6 wk
IVC 75g 1 1/2 wks before surgery. Continue 2x a week
Surg 1/20 -margins T4bN1a IIIC G2 MSI- 1/20 LN+ LVI+ PNI-
pre cea 24 post 5.9
FOLFOX
7 rds 6-10 CEA 11.4 No more
CEA
7/20 11.1 8.8
8/20 7.8
9/20 8.8, 9, 8.6
10/20 8.1
11/20 8s
12/20 8s-9s
ADAPT++++ chrono
CEA
10/23/22 26.x
12/23/22 22.x
2023
1/5 17.1
1/20 15.9
3/30 14.9
6/12 13.3
Nodule RML SUV 1.3 5mm
Rolles 3 of 4 lung nodules cancer
KRAS
Chem-sens test failed Not enough ca cells to test
Re: New trial kras inhibitor
The drug is called bgb-53038 made by beigene. My mutation is kras g12v, I read it’s one of the worst to have in regards to overall survival and recurrence. This drug is a pan kras inhibitor so it inhibits all the kras mutations. They did mention mention that drug but it only inhibits the kras g12c variation which I don’t have.
I’m always I’m impressed beach by your knowledge and treatment plans.
I’m always I’m impressed beach by your knowledge and treatment plans.
09/20:Diagnosed
10/20: LAR tumour t3n2m1 4/24 lymph nodes.
11/20: pet scan confirmed Mets
11/20: folfoxiri - 10/6/21. 12 rounds in total
1/1/21 thoracotomy 1 met removed
2/2022 sabr to 2 lung nodule
09/22 PET scan progression
10/22 phase 1 trial bispecific antibody
9/23 added pd1 blocker
12/23 bilateral VATS all visible (7) lesions removed
3/24 radiation to acromion bone met + chest lymph nodex
8/24 new pet positive lesions in lung and neck lymph nodes. Begin Folfiri.
3/25 phase 1 kras inhibitor trial
10/20: LAR tumour t3n2m1 4/24 lymph nodes.
11/20: pet scan confirmed Mets
11/20: folfoxiri - 10/6/21. 12 rounds in total
1/1/21 thoracotomy 1 met removed
2/2022 sabr to 2 lung nodule
09/22 PET scan progression
10/22 phase 1 trial bispecific antibody
9/23 added pd1 blocker
12/23 bilateral VATS all visible (7) lesions removed
3/24 radiation to acromion bone met + chest lymph nodex
8/24 new pet positive lesions in lung and neck lymph nodes. Begin Folfiri.
3/25 phase 1 kras inhibitor trial
Re: New trial kras inhibitor
Hey Mark,
If you don’t mind me asking, where are you based? In the states?
Also, I see from your signature you had some chest nodes radiated. How many were involved?
Many thanks in advance for sharing!
If you don’t mind me asking, where are you based? In the states?
Also, I see from your signature you had some chest nodes radiated. How many were involved?
Many thanks in advance for sharing!
Re: New trial kras inhibitor
Hi Bianca, I’m in Melbourne Australia. There were 2 lymph nodes in the chest that had radiation, unfortunately it didn’t work as they were still avid on the the next pet scan. After 3 months of chemo they were no longer avid on the pet scan.
09/20:Diagnosed
10/20: LAR tumour t3n2m1 4/24 lymph nodes.
11/20: pet scan confirmed Mets
11/20: folfoxiri - 10/6/21. 12 rounds in total
1/1/21 thoracotomy 1 met removed
2/2022 sabr to 2 lung nodule
09/22 PET scan progression
10/22 phase 1 trial bispecific antibody
9/23 added pd1 blocker
12/23 bilateral VATS all visible (7) lesions removed
3/24 radiation to acromion bone met + chest lymph nodex
8/24 new pet positive lesions in lung and neck lymph nodes. Begin Folfiri.
3/25 phase 1 kras inhibitor trial
10/20: LAR tumour t3n2m1 4/24 lymph nodes.
11/20: pet scan confirmed Mets
11/20: folfoxiri - 10/6/21. 12 rounds in total
1/1/21 thoracotomy 1 met removed
2/2022 sabr to 2 lung nodule
09/22 PET scan progression
10/22 phase 1 trial bispecific antibody
9/23 added pd1 blocker
12/23 bilateral VATS all visible (7) lesions removed
3/24 radiation to acromion bone met + chest lymph nodex
8/24 new pet positive lesions in lung and neck lymph nodes. Begin Folfiri.
3/25 phase 1 kras inhibitor trial
Re: New trial kras inhibitor
Mark,
How is the drug trial going? I hope you are doing well with it and not experiencing too many harsh symptoms. I wish you the very best of luck and hope this drug works for you.
Paige
How is the drug trial going? I hope you are doing well with it and not experiencing too many harsh symptoms. I wish you the very best of luck and hope this drug works for you.
Paige
02/20 Rectal Cancer dx - 4 cm mass; located 9 cm from AV
CEA 1.4; 0.9; 0.9; 1.2; 1.0; 0.8; 1.1; 1.0; 1.1; 1.7; 1.8; 1.8; 1.9
2.4; 2.3; 2.8; 2.2, 2.8, 3.2; 3.0; 1.6; 2.0; 1.2; 1.4; 1.2; 1.0; 1.2; 1.2
04/20 ST Radiation; 04/20 LAR surgery w/ileostomy; ypT3N1bM0; MSS, KRAS G12A
05/20 CAPEOX; 08/20 Ileostomy reversal
12/20 CT scan; lung nodules (watch and wait);
11/22 lung nodule biopsy positive for RC met;
1/23 VATS right lower lobe wedge resection
FOLFIRI 10 cycles
4/24 left brain craniotomy (RC met)
CEA 1.4; 0.9; 0.9; 1.2; 1.0; 0.8; 1.1; 1.0; 1.1; 1.7; 1.8; 1.8; 1.9
2.4; 2.3; 2.8; 2.2, 2.8, 3.2; 3.0; 1.6; 2.0; 1.2; 1.4; 1.2; 1.0; 1.2; 1.2
04/20 ST Radiation; 04/20 LAR surgery w/ileostomy; ypT3N1bM0; MSS, KRAS G12A
05/20 CAPEOX; 08/20 Ileostomy reversal
12/20 CT scan; lung nodules (watch and wait);
11/22 lung nodule biopsy positive for RC met;
1/23 VATS right lower lobe wedge resection
FOLFIRI 10 cycles
4/24 left brain craniotomy (RC met)
Re: New trial kras inhibitor
Hi Paige,
It’s been about 2 weeks since I started and side effects are very minor just had one bout of diarrhea and some nausea and lethargy, nothing compared to chemo. I think the hardest thing is I have to fast 2 hours before taking the tablets and one hour after.
I haven’t noticed any difference in the lymph nodes I can feel in my neck but hopefully it’s just too early to feel any difference. I have a ct scan in 2 months and will update when I get the results
It’s been about 2 weeks since I started and side effects are very minor just had one bout of diarrhea and some nausea and lethargy, nothing compared to chemo. I think the hardest thing is I have to fast 2 hours before taking the tablets and one hour after.
I haven’t noticed any difference in the lymph nodes I can feel in my neck but hopefully it’s just too early to feel any difference. I have a ct scan in 2 months and will update when I get the results
09/20:Diagnosed
10/20: LAR tumour t3n2m1 4/24 lymph nodes.
11/20: pet scan confirmed Mets
11/20: folfoxiri - 10/6/21. 12 rounds in total
1/1/21 thoracotomy 1 met removed
2/2022 sabr to 2 lung nodule
09/22 PET scan progression
10/22 phase 1 trial bispecific antibody
9/23 added pd1 blocker
12/23 bilateral VATS all visible (7) lesions removed
3/24 radiation to acromion bone met + chest lymph nodex
8/24 new pet positive lesions in lung and neck lymph nodes. Begin Folfiri.
3/25 phase 1 kras inhibitor trial
10/20: LAR tumour t3n2m1 4/24 lymph nodes.
11/20: pet scan confirmed Mets
11/20: folfoxiri - 10/6/21. 12 rounds in total
1/1/21 thoracotomy 1 met removed
2/2022 sabr to 2 lung nodule
09/22 PET scan progression
10/22 phase 1 trial bispecific antibody
9/23 added pd1 blocker
12/23 bilateral VATS all visible (7) lesions removed
3/24 radiation to acromion bone met + chest lymph nodex
8/24 new pet positive lesions in lung and neck lymph nodes. Begin Folfiri.
3/25 phase 1 kras inhibitor trial
-
beach sunrise
- Posts: 1220
- Joined: Thu Mar 05, 2020 7:14 pm
Re: New trial kras inhibitor
I have been thinking about you! I am happy for you that it is not a harsh side effect treatment. Thank you for the update.
8/19 RC CEA 82.6 T3N0M0
5FU/rad 6 wk
IVC 75g 1 1/2 wks before surgery. Continue 2x a week
Surg 1/20 -margins T4bN1a IIIC G2 MSI- 1/20 LN+ LVI+ PNI-
pre cea 24 post 5.9
FOLFOX
7 rds 6-10 CEA 11.4 No more
CEA
7/20 11.1 8.8
8/20 7.8
9/20 8.8, 9, 8.6
10/20 8.1
11/20 8s
12/20 8s-9s
ADAPT++++ chrono
CEA
10/23/22 26.x
12/23/22 22.x
2023
1/5 17.1
1/20 15.9
3/30 14.9
6/12 13.3
Nodule RML SUV 1.3 5mm
Rolles 3 of 4 lung nodules cancer
KRAS
Chem-sens test failed Not enough ca cells to test
5FU/rad 6 wk
IVC 75g 1 1/2 wks before surgery. Continue 2x a week
Surg 1/20 -margins T4bN1a IIIC G2 MSI- 1/20 LN+ LVI+ PNI-
pre cea 24 post 5.9
FOLFOX
7 rds 6-10 CEA 11.4 No more
CEA
7/20 11.1 8.8
8/20 7.8
9/20 8.8, 9, 8.6
10/20 8.1
11/20 8s
12/20 8s-9s
ADAPT++++ chrono
CEA
10/23/22 26.x
12/23/22 22.x
2023
1/5 17.1
1/20 15.9
3/30 14.9
6/12 13.3
Nodule RML SUV 1.3 5mm
Rolles 3 of 4 lung nodules cancer
KRAS
Chem-sens test failed Not enough ca cells to test
Re: New trial kras inhibitor
Fingers crossed for you Marksdale, thank you for being on the frontlines for all the cancer patients with that stupid Kras mutation! Do keep us posted, and I really hope you see those lymph nodes resorb at the next scan (we need a "fingers and toes crossed" emoji!)
Wife of Dx 04/18 (51 yo). MSS, KRAS G12A, no primary
Tumors: L4 04/18; left adrenal gland & small lung nodules 03/19
rectum 02/22 (pT3 pN0 stage 2A); L3 09/22
Surgeries: intestinal resect. 05/18 (no cancer - Crohn's); adrenalectomy 02/20
L3-L4-L5 fusion and corpectomy 05/20; LAR 04/22; ileo reversal 09/22
L2-L3 fusion and corpectomy 09/22
Treatments: EBRT 04/18; SBRT 02/19; Failed adjuvant Xelox ; Folfiri/Avastin 03/19 - 01/20
adjuvant chemorad (Xeloda) 06/22; SBRT 11/22; Xeloda/Avastin since 01/24
Tumors: L4 04/18; left adrenal gland & small lung nodules 03/19
rectum 02/22 (pT3 pN0 stage 2A); L3 09/22
Surgeries: intestinal resect. 05/18 (no cancer - Crohn's); adrenalectomy 02/20
L3-L4-L5 fusion and corpectomy 05/20; LAR 04/22; ileo reversal 09/22
L2-L3 fusion and corpectomy 09/22
Treatments: EBRT 04/18; SBRT 02/19; Failed adjuvant Xelox ; Folfiri/Avastin 03/19 - 01/20
adjuvant chemorad (Xeloda) 06/22; SBRT 11/22; Xeloda/Avastin since 01/24
Re: New trial kras inhibitor
Had a ct scan to track the Mets while on the trial drug. In the 2 that are being tracked they grew approx 2mm each in 2 months one is 4cm the other 1 cm. They are classing it as stable but my cea continues to rise.
Feels like it has slowed the growth if I compare to previous scan. I told them I’ll continue on it just because there’s are limited side effects. Not sure what I can do next
Feels like it has slowed the growth if I compare to previous scan. I told them I’ll continue on it just because there’s are limited side effects. Not sure what I can do next
09/20:Diagnosed
10/20: LAR tumour t3n2m1 4/24 lymph nodes.
11/20: pet scan confirmed Mets
11/20: folfoxiri - 10/6/21. 12 rounds in total
1/1/21 thoracotomy 1 met removed
2/2022 sabr to 2 lung nodule
09/22 PET scan progression
10/22 phase 1 trial bispecific antibody
9/23 added pd1 blocker
12/23 bilateral VATS all visible (7) lesions removed
3/24 radiation to acromion bone met + chest lymph nodex
8/24 new pet positive lesions in lung and neck lymph nodes. Begin Folfiri.
3/25 phase 1 kras inhibitor trial
10/20: LAR tumour t3n2m1 4/24 lymph nodes.
11/20: pet scan confirmed Mets
11/20: folfoxiri - 10/6/21. 12 rounds in total
1/1/21 thoracotomy 1 met removed
2/2022 sabr to 2 lung nodule
09/22 PET scan progression
10/22 phase 1 trial bispecific antibody
9/23 added pd1 blocker
12/23 bilateral VATS all visible (7) lesions removed
3/24 radiation to acromion bone met + chest lymph nodex
8/24 new pet positive lesions in lung and neck lymph nodes. Begin Folfiri.
3/25 phase 1 kras inhibitor trial
Return to “Colon Talk - Colon cancer (colorectal cancer) support forum”
Who is online
Users browsing this forum: No registered users and 38 guests